Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-000298-20Phase 3Terminated
Phase 3 trial of chloroprocaine and ropivacaine (2 arms), sponsored by Sintetica. Primary endpoint: Time to onset of anaesthesia. Started Sep 2016; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-000298-20.